Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways.

Janowski, Michal; Ulanczyk, Zofia; Luczkowska, Karolina; Sobus, Anna; Roginska, Dorota; Pius-Sadowska, Ewa; Gniot, Michal; Kozlowski, Krzysztof; Lewandowski, Krzysztof; Helbig, Grzegorz; Machalinski, Boguslaw; Paczkowska, Edyta.

Afiliación

Janowski M; Department of Hematology and Transplantology, Pomeranian Medical University, Szczecin, Poland.
Ulanczyk Z; Department of General Pathology, Pomeranian Medical University, Szczecin, Poland.
Luczkowska K; Department of General Pathology, Pomeranian Medical University, Szczecin, Poland.
Sobus A; Department of General Pathology, Pomeranian Medical University, Szczecin, Poland.
Roginska D; Department of General Pathology, Pomeranian Medical University, Szczecin, Poland.
Pius-Sadowska E; Department of General Pathology, Pomeranian Medical University, Szczecin, Poland.
Gniot M; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
Kozlowski K; Department of Constitutional Law, Faculty of Law and Administration, Jagiellonian University in Krakow, Krakow, Poland.
Lewandowski K; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
Helbig G; Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland.
Machalinski B; Department of General Pathology, Pomeranian Medical University, Szczecin, Poland.
Paczkowska E; Department of General Pathology, Pomeranian Medical University, Szczecin, Poland.